Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Sclerosis · RRMS · Relapsing Remitting MS

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Byers Hall, San Francisco, California, United States
Contact: Study coordinator (Harkee S Halait, BS) · harkeerat.halait@ucsf.edu · 415-745-1304
Contact: Study coordinator (Angelica Montevirgen, BS) · angelica.montevirgen@ucsf.edu
Contact: Principal Investigator (Ari J Green, MD, MCR)
Jeremy Gordon, PhD (Sub-investigator)

Study leads

Ari Green, MD
Principal Investigator
University of California, San Francisco

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis (RRMS) · Anti-CD20 Therapy

Abroad (travel likely)RecruitingPHASE3

Montpellier, France

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

Progressive Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Kogarah, Australia · New Lambton Heights, Australia

Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis

Multiple Sclerosis · Insomnia

Abroad (travel likely)RecruitingPHASE2

Kansas City, United States

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

Multiple Sclerosis · Multiple Sclerosis Fatigue

Abroad (travel likely)RecruitingPHASE2

Baltimore, United States